TFN eNews 09/09/2009: Look what this Canadian copper miner did for us in less than a week!
Published via e-mail broadcast on September 9, 2009
In today’s TFN eNews:
* Buyout rumors power this swine flu protagonist
* The petroleum edition of Risk
* 76.8% gains on this Canadian copper miner… in less than a week!
Dear TFN Reader,
If you were worried that China would stop pumping money into the expansion and acquisition of resources, don’t worry.
China National Petroleum Corp. (CNPC), the parent company of PetroChina (NYSE:PTR), just received a $30 billion loan to fund overseas expansion.
The five-year loan was provided at a discounted interest rate by the faithful Comrades at the state-run China Development Bank.
China has been plowing over $12 billion into the acquisitions of energy resources abroad so far this year, mostly on oil fields and refining assets in countries including Singapore and Canada. An interesting approach: While the current U.S. administration is doing its darndest to cap and shrink its domestic oil industry… or at least drive their headquarters offshore… China is looking at the world like a game of Risk.
*** And as Washington keeps adding to its grandiose and unpaid-for social engineering schemes, the dollar keeps falling.
Commodities…well, what exactly are commodities doing? Depending on when you happen to look, they’re either dropping on justified expectations of sustained economic shrinkage. Or rising on hyper-active rumors that somehow the Chinese will manage to buy ‘em all up.
We don’t mind either way: Our Hot Stock Confidential open positions portfolio has both short and long positions on key commodities. Currently, our short position on gold is down, thanks to gold prices of over $1,000 per ounce. But our silver plays are up..31%…17%… and 9%, respectively!
Better even, the Canadian copper and cobalt miner we recommended last Thursday is going through the roof right now!
Katanga Mining (TSE:KAT) announced today “its intention to accelerate the ramp-up of its project in the Katanga Province in the Democratic Republic of Congo to 150,000 tons of copper and 8,000 tons of cobalt per annum through the earlier completion of the construction of Phases 3 and 4.”
I’m big on the announcements of plans. As is the President. How far these plans are supportive of actual investment decisions, I leave to your judgment. But I wasn’t at all that judgmental when I saw that investors were pouring money into our Toronto-traded Copper Kaiser of the Congo.
On September 3, we had recorded our entry price at C$0.56. Today, the stock was trading at C$0.96 on moderately good news.
We did our usual song-and-dance routine at the office: Stop loss at 65%? Sell half? Let it ride? Finally, I decided to sell the news and take the gains. Our sell alert locked in 76.8% gains for our members in less than a calendar week… or 4 trading days.
I’d love to take credit for picking this one… but this stock was suggested for further scrutiny by HSC Member Chris W.
This, by the way, is double-digit gainer #55 so far this year for HSC members. See the fun you’re missing? We’ve now averaged 21.4% gains on our 66 closed positions, with an average holding period of 54 days. And if Ms. Cadden would only let me, I’d be imitating my colleagues in the newsletter industry touting “cumulative” gains of 1,415.1%.
But I won’t, hoping that you’ll be tempted to join our HSC premium service members out of your own volition!
*** Speaking of gains..
Our Hibernian Ace of Affluence Laura Cadden updated us on her biopharma pick Vical (NASDAQ:VICL), which hit 52-week highs today:
“The share price for VICL jumped over 15% earlier this month on the news that a U.S. patent had been granted for its Vaxfectin-formulated DNA influenza vaccines. Now rumors of a buyout offer from generic drug giant Teva Pharmaceuticals Ltd. (NASDAQ:TEVA) are turning this company into a superstar!
“We saw the potential for Vical here at TFN. Readers that acted on our free recommendation of VICL in our Aug. 20 Report, The Top 6 Swine Flu Vaccine Stocks Under $20 are sitting on gains of around 46%!
“Those rumors could prove true: In early August, Vical announced an agreement with a subsidiary of Teva, Abic Marketing Limited, allowing Abic exclusive marketing rights for the company’s drug Allovectin-7 in Israel. In return, Vical is to receive upfront and milestone payments.
“The company is currently enrolling patients for the Phase III trial of Allovectin-7 in Israel for the treatment of metastatic melanoma. Teva may perceive Vical as a worthwhile purchase. If you own shares of Vical, we recommend you hold on for now.”
*** “This is definitely the most bang for the buck. I appreciate the service HSC gives. I’ll probably be a lifer!”
We’d like to hear from other satisfied customers… that includes you, too! Give it some thought: http://www.todaysfinancialnews.com/HSC/PROXY/EHSCK801.html
Quote of the Day:
“Why has the Democratic Party become so arrogantly detached from ordinary Americans? Though they claim to speak for the poor and dispossessed, Democrats have increasingly become the party of an upper-middle-class professional elite, top-heavy with journalists, academics and lawyers (one reason for the hypocritical absence of tort reform in the healthcare bills). Weirdly, given their worship of highly individualistic, secularized self-actualization, such professionals are as a whole amazingly credulous these days about big-government solutions to every social problem. They see no danger in expanding government authority and intrusive, wasteful bureaucracy. This is, I submit, a stunning turn away from the anti-authority and anti-establishment principles of authentic 1960s leftism.”
– Camille Paglia, Salon.com
Recommended Reading:
The safest market strategy for the Fall of 2009
The Top Alternative Energy Stocks Under $6
The Top Swine Flu Vaccine Stocks under $20
The 3 Best Chinese Stocks Under $5!
Today’s Top 3 Financial News Stories:
APNews.com – Taxpayers face heavy losses on auto bailout “The Congressional Oversight Panel did not provide an estimate of the projected loss in its latest monthly report on the $700 billion Troubled Asset Relief Program. But it said most of the $23 billion initially provided to General Motors Corp. and Chrysler LLC late last year is unlikely to be repaid.”
WSJ.com — Stocks Rise, Dollar Keeps Falling “The dollar slipped against all six foreign denominations in the U.S. Dollar Index, including the euro, Japanese yen, and British pound. The index, which fell 1% on Tuesday, was recently down 0.5%.”
Bloomberg.com – China Growing 9.5% Evident as New Vehicle Sales Soar “Look no further than Alcoa Inc. and General Motors Co. for evidence that the Chinese economy is poised to accelerate even after a slump in lending growth dragged down the nation’s stock market.”
Cordially yours,
J. Christoph Amberger
Executive Publisher, TodaysFinancialNews.com
Next Article: Dynavax (DVAX) soars on good news. HSC takes 81% gains in 3 weeks!
Be the first to leave a reply.
Your comments are welcome
Follow TFN via RSS or Twitter |
 |
 |
 |
Advertisement
Latest Headlines
- The Big Picture for Sinobiopharma, Inc. (SNBP)
- Beazer Homes USA, Inc. (BZH) and Hovnanian Enterprises, Inc. (HOV) up despite horrid housing news
- The FDA catalyst: 2010 moves in MannKind (MNKD), Roche Holding (RHHBY), Acorda Therapeutics (ACOR) show it still works!
- Steepest drop since Feb. 2009: Here we go again!
- Is the silver run over? Coeur d’Alene Mines (CDE), Silver Wheaton (SLW), Alto Group (ALTO), Hecla Mining (HL), Endeavour Silver (EXK) close down